← FDA DRUG APPROVALS

FDA ANDA · ANDA212296

DEOXYCHOLIC ACID

Sponsor: WILSHIRE PHARMS INC

APPLICATION
ANDA212296
TYPE
ANDA
ORIGINAL APPROVAL
2021-04-02
LATEST ACTION
2023-06-29
ROUTE
SUBCUTANEOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

DEOXYCHOLIC ACIDPrescription
DEOXYCHOLIC ACID 20MG/2ML (10MG/ML) · SOLUTION · SUBCUTANEOUS

Approval history

2023-06-29Labeling · Supplement 1 · standardAP
2021-04-02UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →